Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer

Published:2020-08 Issue: Volume:85 Page:106613
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wu Zhuzhu,Man Shuai,Sun Rui,Li Zengqiang,Wu Yingliang,Zuo Daiying

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference136 articles.

1. Global cancer statistics;Torre;CA Cancer J. Clin.,2012

2. Cancer statistics in China;Chen;CA Cancer J. Clin.,2015

3. SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4;Li;J. Exp. Clin. Cancer Res.,2018

4. Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer;Ng;Cancer,2019

5. Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer;Bobbili;PLoS ONE,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognosis and metabolite changes of NSCLC patients receiving first‐line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification;Cancer Medicine;2024-09

2. The predictive value of E2F7 in immunotherapy efficacy for lung adenocarcinoma: An observational study;Medicine;2024-06-21

3. DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model;Biomolecules;2024-03-25

4. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy;Drug Delivery and Translational Research;2024-03-01

5. Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma;Cancer Biology & Therapy;2023-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3